GlaxoSmithKline has high hopes for its standalone consumer health business, Haleon, when it launches in July. Haleon is targeting organic annual sales growth of 4-6% over the medium term, which CEO-designate Brian McNamara said will be achieved, in part, by reaching new consumers with its products.
GSK's Haleon Sets Its Sights On Improving Health Inclusivity
As GSK prepares to launch its standalone consumer health business, Haleon, Tess Player, global head of expert and influencer marketing, talks to HBW Insight about the new company's plans to improve health inclusivity globally and empower 50 million consumers per year to self-care by 2025.
